Find an expert

Professor Soyer is an academic dermatologist with over 30 years experience in the field. He was appointed as the inaugural Chair in Dermatology by The University of Queensland (UQ) in 2007 and was Director of the Princess Alexandra Hospital (PAH) Dermatology Department from 2008-2023. His clinical background drives a strong focus on translational skin cancer research.

Professor Soyer is internationally recognised in the field of dermatology with particular expertise in the areas of preventative dermatooncology, dermatopathology and dermatologic imaging (dermoscopy and reflectance confocal microscopy). Within the dermatology discipline he is a pioneer and world leader in the field of dermoscopy of pigmented skin lesions, a non-invasive diagnostic method. He has led the development of the morphologic classification system currently used worldwide.

His main research focus is skin cancer (both melanoma and keratinocyte skin cancer), with a particular interest in technological innovations and their ability to impact early detection strategies and expand the concept and applications of teledermatology and teledermoscopy. A $9.9M infrastructure grant awarded in 2018 by the Australian Cancer Research Foundation (ACRF) has enabled establishment of the collaborative Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID); installing 15 3D total body imaging systems, linked by a research network, across Australia’s east cost to facilitate research in the early detection of melanoma. ACRF ACEMID is currently conducting Australia’s largest melanoma cohort study targeting 15,000 participants, with the multi-modal research data being collected and stored in a national research repository. This unprecedented data resource will allow many unanswered research questions in the field to be addressed and will facilitate advancements in artificial intelligence, resulting in the development of reliable, evidence-based solutions to transform melanoma early detection.

Professor Soyer has an extensive publication record with over 680 publications to date, with more than 700 citations per year (in the last 5 years) and an h-index of 96 (Google Scholar). His textbook entitled "Dermoscopy - The Essentials 3rd Edition", co-authored with G Argenziano, R Hofmann-Wellenhof and I Zalaudek is considered a world-leading textbook in the field.

Professor Soyer has been awarded two competitive fellowships while at UQ: a Medical Research Future Fund (MRFF) Next Generation Clinical Researchers Program Practitioner Fellowship (2018-2022) and an NHMRC Practitioner Fellowship (2012-2016). The NHMRC Practitioner Fellowship was acknowledged in the NHMRC ‘10 of the Best NHMRC research projects 2016’ publication. He has also been awarded 1 NHMRC European Union Collaborative Research Grant (CIA), 1 NHMRC Synergy Grant (CIC), 1 NHMRC Clinical Trials and Cohort Studies Grant (CIC), 1 MRFF Targeted Health System and Community Organisation Research Grant (CIC), 3 NHMRC Centre of Research Excellence Grants (CIA, CIB, CIE), 4 NHMRC Project Grants (CIA, CIA, CIB, CID), 2 NHMRC Partnership Grants (CIA, CIB), 2 ARC Discovery Project Grants (CIB, CID), and a Queensland Genomic Health Alliance (QGHA) Demonstration Project Grant (CIA), with many additional projects funded through other competitive, industry and philanthropic funding sources. In total, through his involvement as an investigator, he has achieved over $43M in research funding for UQ since 2014.

Associate Professor Spurling works at The University of Queensland General Practice Clinical Unit (0.4 FTE) and at the Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander primary health care (Inala COE – 0.6 FTE). He has research interests in social determinants of health and access to primary health care, especially where his research skills can be of service to Aboriginal and Torres Strait Islander peoples. His other research interests are quality use of medicines and respiratory infections, with particular methodological interests in systematic reviews and mixed-methods research in general practice. His most recent research interest concerns access to opioid dependence treatment in general practice.

He completed medical training at the University of Queensland, did his junior doctor years in regional Queensland and completed a Diploma of Tropical Medicine and Hygiene in London in 1998. In 2001, he spent 12 months working on a project in Central America with Médecins Sans Frontières. He completed general practice specialty training with the RACGP in 2004, which included an academic registrar term. In 2004, he was fortunate to meet Professor Noel Hayman, one of Queensland’s first Aboriginal medical graduates and Clinical Director of the Inala COE, who offered him a GP position in 2004. He has shared his full-time work as a GP academic at the Inala COE and UQ GPCU ever since.

Associate Professor Spurling has developed clinical interests in serving the Aboriginal and Torres Strait Islander community in Inala, serving Spanish-speaking refugees, diabetic retinopathy, and, most recently, addiction medicine. He has been mentoring GP registrars and medical students at the Inala COE since 2004. As a member of the UQ GPCU academic staff, he regularly takes tutorial groups and lectures in cardiovascular medicine, respiratory infections, Aboriginal and Torres Strait Islander health and social determinants of health for medical students doing their general practice rotation.

Associate Professor Spurling supervises five postgraduate students (PhD students). He has been awarded over A$18M in research grants and has published over 80 peer-reviewed papers.

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

• Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
• Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
• Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
• Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
• Improving gentamycin dosing in paediatric oncology patients
• Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
• Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
• Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

• Dose optimisation of busulfan in paediatric bone marrow transplant recipients
• Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
• Examining Bayesian forecasting methods to predict immunosuppressant exposure
• Examining the international use of immunosuppressant and anti-rheumatic drugs
• Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

• PHRM3052- Biological Fate of Drugs

Teaches in:

• PHRM3052- Biological Fate of Drugs
• PHRM3011- Quality Use of Medicines

My work focusses on activation of innate immune cells by pathogen products. Following my PhD at UQ on transcriptional regulation in macrophages I went in 1996 to the University of Cambridge on a CJ Martin Fellowship to work in a molecular parasitology laboratory. I returned to the the University of Queensland in where I focussed on immune cell responses to foreign DNA. I was awarded an ARC Future Fellowship in 2009 to move to the School of Chemistry and Molecular Bioscience, where I also lecture in immunology.

Dr Hana Starobova is a pharmacist and NHMRC research fellow at the Sensory Neuropharmacology Group at the University of Queensland (UQ). She works under the mentorship of Prof. Vetter, and as an early career researcher, she is working toward an independent research career as a group leader. She obtained her PhD in 2020 from the Institute for Molecular Bioscience, UQ, and continued here to conduct studies as a Children Hospital Foundation Fellow (2021-2023) in the areas of cancer therapy-induced adverse and late effects with the main focus on neuropathies. Over the past four years, she has developed a research program focusing on the understanding of cancer therapy-induced adverse and late effects with a special interest in children, and established innovative transcriptomic and microscopy pipelines, in vitro assays, adult and juvenile models of adverse and late effects following mono- and combination chemotherapy and radiotherapy, assays for the assessment of adverse effects including cognition and neuropathies, as well as cancer models. Knowledge impact arising from her research program has been disseminated in 18 peer-reviewed publications, having together attracted >1,100 citations (h-index 15, i10-index 18, Google Scholar, May 2024).

Dr Sally Staton is a Senior Research Fellow in the Science of Learning Research Centre at the Queensland Brain Institute, UQ. Dr Staton has a strong commitment to research that can inform and ensure positive early life experience for all children. Her research focuses on the role of early education and care settings in supporting young children’s immediate and on-going social-emotional, cognitive and physical development. Dr Staton’s research spans a range of study designs and methodologies, including evaluation studies in educational settings (applying randomised control trial and quasi-experimental designs), longitudinal studies tracking large child cohorts (>2000 children), standard observation techniques (in vivo and video), survey and individualised standard child assessment (using educational and psychological measures), as well as studies employing physiological (cortisol, actigraphy, heart rate variability) and qualitative (child, educator and parent interviews, socio-metric) designs. She has a particular expertise in the development, application and interpretation of observational measurement for educational practices and teacher-child interactions in education contexts, including early childhood settings. Dr Staton has a strong track record in research translation and community engagement, including delivery of reports for government and non-government organisations, professional development packages for early childhood professionals and teachers, presentations, workshops, videos and articles for parents, government regulatory officers and the early childhood sector. In 2016, she was named among Queensland’s Young Tall Poppy Scientists for her contribution to science translation and engagement. In 2019 her succesful research partnerships with industry and government was acknowledged in a Partners in Research Excellence Award from UQ.

I completed my Bachelor of Pharmacy at Kings College London, followed by pre-registration and subsequent employment as a pharmacist with Boots the Chemists in Central London. With a PhD in plant biochemistry with Royal Holloway College, University of London, and the Royal Botanic Gardens, Kew, I moved first to Cornell University, USA and then The University of Western Australia for postdoctoral research. I moved to the School of Pharmacy at The University of Queensland in 2007.

Following a number of years in plant research, my current research interests generally link back to plants in some way. Many of my projects develop in response to requests for help from healthcare professionals, and so I have a strong focus on answering clinical questions using pharmaceutical science methods. See my research interests for more information.

I teach into the Bachelor of Pharmacy (Honours) in the areas of pharmaceutics, compounding and complementary medicines. I also teach the clinical drug development course for our Master of Pharmaceutical Industry Practice. I am currently the Director of Teaching, Learning and Student Experience for the School of Pharmacy. I have supervised 28 PhD students to completion, and over 60 undergraduate and masters independent research project students.

Assoc. Prof. Stephan is an anatomist and forensic anthropologist with research interests in skeletal analysis and identification in the medicolegal setting. Specifcally these research interests include: craniofacial identification, radiographic comparison, trauma, unmingling of skeletons, biological profile estimations and standards of practice. Carl heads the Laboratory for Human Craniofacial and Skeletal Identification (HuCS-ID Lab), and is Chief Anatomist at The University of Queensland (UQ) School of Anatomy.

Carl is a Fellow of The American Academy of Forensic Sciences and recent past President of the International Association of Craniofacial Identification. Carl served as Special Issue Managing Guest Editor for Forensic Science International, Latest Progress in Craniofacial Identification, 2018. He has been Editorial Board Member of the Journal of Forensic Sciences (2013-23) and Associate Editor of Forensic Anthropology (2016-20). Carl founded the SBMS Skeletal Collection and Skeletisation Program at UQ in late 2014, re-energising forensic osteology within the UQ School of Anatomy and more broadly within the School of Biomedical Sciences.

Carl's prior appointments include forensic anthropology analyst with the Iraq Mass Graves Investigation Team (USA Army Corps of Engineers on behalf of the USA Department of Justice) and ORISE researcher at the USA Department of Defence Central Identification Laboratory in Hawaii. He often now serves as an external consultant to the USA Defence POW/MIA Accounting Agency (DPAA). At UQ and as Chief Anatomist and School of Anatomy manager, Carl works very closely with the SBMS Gross Anatomy Facility, in all matters of anatomy teaching, research and governance management.

Working in joint with the GAF Manager, Carl has cross adapted ISO17025 style practices and auditing procedures to the UQ School of Anatomy space and introduced the first Code-of-Practice for Use of Human Tissues within the UQ School of Anatomy since its inauguration (1927). These accreditation-style policies and procedures are further implemented and expanded in the HuCS-ID Lab, providing vital learning experiences and skill sets for Honours and Higher Research Degree students wanting to pursue careers in forensic science. New data analytic, casework and research tools developed by the HuCS-ID Lab and in the statistical environment of R, are freely and routinely released for others to use at the website: CRANIOFACIALidentification.com.

Carl's research outputs currently exceed 100 total scientific publications, including more than 85 full-length research articles..

Michele Sterling is a NHMRC Leadership Fellow (leadership level 2), Professor in the Recover Injury Research Centre, Program Lead of the Musculoskeletal Injury research program and Director of the NHMRC Centre of Research Excellence (CRE) in Better Health Outcomes for Compensable Injury. She is a Musculoskeletal Physiotherapist and a Fellow of the Australian College of Physiotherapists. She is internationally recognised for her research on whiplash-associated disorders. Michele’s research focusses on the mechanisms underlying the development of chronic pain after injury, predictive algorithms for outcomes and developing effective interventions for musculoskeletal injury and pain. She has received over $50M in research funding from the NHMRC, MRFF, ARC and industry partners, including 7 NHMRC project grants, and 2 Centres of Research Excellence. Michele holds editorial roles with several leading journals and textbooks, including being a Section Editor of PAIN and co-editors of the 4th and 5th editions of the seminal physiotherapy textbook 'Grieve's Musculoskeletal Physiotherapy). Michele has published over 325 scientific works and has received numerous awards for her research including the Research Australia Research Translation award in 2023. Examples of recognition as a national and international leader in the field include:

2024- Secretary of the Executive Council - International Association for the Study of Pain (IASP)

2022-2024 Chair Scientific Program Committee World Pain Congress, Amsterdam 2024

2023-2027 NHMRC Leadership Fellow (Level 2) for research of road traffic injury.

2023 Research Australia Research Translation award

2016-2022 Council member International Association for the Study of Pain (IASP)

Associate Professor Steyn is a leading expert in neurodegenerative disease research, specializing in the metabolic and physiological aspects of Motor Neurone Disease (MND). He currently directs a comprehensive translational research program at the University of Queensland, focusing on the interplay between metabolism and disease progression in MND, and leads key projects investigating the impact of metabolic dysfunction, appetite dysregulation, and hypermetabolism on patient outcomes. His work prioritizes the integration of pre-clinical models, clinical studies, and innovative digital health technologies to advance understanding of the heterogeneity in MND, patient care and therapeutic development.

Associate Professor Steyn’s career began with detailed investigations into the hypothalamic regulation of energy homeostasis, growth, and reproduction. He developed industry-standard methodologies for evaluating hormone release patterns in rodent models, particularly concerning growth hormone regulation. In 2015, he transitioned to focus on neurodegenerative diseases, establishing a research platform at UQ that has significantly advanced the analysis of metabolic phenotypes in MND.

His current research projects include the MEND-MND study, which explores how altered energy metabolism influences disease progression, and the EATT4MND study, which examines the consequences of appetite loss and impaired body weight regulation on disease outcomes. Through collaboration with industry partners, he is also developing novel therapeutic strategies and refining wearable digital health technologies for precise, real-time monitoring of disease progression, including the validation of actigraphy-based measures as clinical trial biomarkers.

I am a medicinal and organic chemist

Studied organic chemistry at the University of Sydney, moved to UQ in 1993, then worked for Bayer in Germany, before moving back to Australia in 1996. Worked in Melbourne at the Victorian College of Pharmacy (now MIPS). I then returned to UQ in 2000 to the Fairlie lab where we design and synthesise new chemical entities to tackle human disease. Since 2012 I have been on extended medical leave and am currently an Adjunct Research Fellow, researching proteins from flaviviruses such as Dengue, West Nile, and Zika viruses, and the coronaviruses SARS, MERS, and SARS-CoV-2.

Dr Nicole Stormon is a Senior Lecturer at the University of Queensland and AHPRA registered Oral health therapist. The current and inaugural Program Convenor for the School of Dentistry’s Doctor of Dental Medicine. She is also the Principal Research Fellow for Queensland Health Metro North Community and Oral Health. An alumnus of the University of Queensland for her undergraduate and postgraduate training, Nicole has become an internationally recognised leader and advocate in Oral Health Therapy.

Nicole Stormon has publications in high quality journals, numerous conference presentation and research collaborations. Health service research is a central theme of her research, with ongoing collaborations with Queensland Health to develop evidence-based and cost-effective models of dental care. She has extensive experience in the analysis of complex quantitative health service data and large longitudinal cohort studies. Additionally, Nicole is experienced in relevant health services research methods including qualitative, scoping methods and consumer engagement. Translating evidence into practice can be challenging, however her research aims to implement innovations and generate new knowledge to better patients oral health outcomes. Being a clinician herself and her effective collaborations to the health service are key to bridging the knowledge-implementation gap.

Nicole Stormon represents the oral health workforce and applies expertise, leadership and governance skills. As an advocate for oral health, she has consulted on a number of national oral health policy issues. Called as an expert witness into the Aged Care Royal Commission into oral health. She has contributed to countless written submissions and representations on national and local advocacy and policy matters. As a leader and advocate for her profession, saw through the recognition and implementation of oral health professionals in obtaining provider numbers and claiming within the Child Dental Benefits Schedule. She has contributed to ongoing public policy issues and has published evaluations of the federal funding policy the Child Dental Benefits.

Professor Jennifer Stow is a molecular cell biologist, an NHMRC Leadership Fellow and head of the Protein Trafficking and Inflammation research laboratory in The University of Queensland’s Institute of Molecular Bioscience (IMB). Her previous leadership appointments include as Division Head and Deputy Director (Research) at IMB (12 years) and she currently serves on national and international advisory boards, editorial boards and steering committees, and as an elected Associate Member of the European Molecular Biology Organisation (EMBO).

Jenny Stow received her undergraduate and PhD qualifications at Melbourne’s Monash University before undertaking postdoctoral training in the Department of Cell Biology at Yale University School of Medicine, USA. With training as a microscopist in kidney research, she gained further experience at Yale as a postdoc in the lab of eminent cell biologist and microscopist, Dr Marilyn Farquhar, where protein trafficking was both a theme and a passion. Jenny then took up her first faculty appointment as an Assistant Professor in the Renal Unit at Massachusetts General Hospital (MGH) and Harvard Medical School in Boston USA, where her research uncovered new roles for a class of enzymes, GTPases, in regulating trafficking within cells. At MGH her research also formed part of a highly successful NIH Renal Cell Biology Program. In late 1994, Jenny moved her research lab back to Australia, to The University of Queensland, in late 1994 as a Wellcome Trust International Medical Research Fellow. As part of IMB since, the Stow lab has continued a focus on protein trafficking, including pioneering live-cell imaging, to spearhead their work on trafficking in inflammation, cancer and chronic disease. Major discoveries include identifying new proteins and pathways for recycling adhesion proteins in epithelial cells, inflammatory cytokine secretion in macrophages and immune signalling through Toll-like receptors in inflammation and infection. Small GTPases of the Rab family, signalling adaptors and kinases feature among the molecules studied in the Stow lab for their functional roles and their potential as drug targets in inflammation and cancer. A keen focus is to understand the role of the fluid uptake pathway, macropinocytosis, in controlling inflammation, cancer and mucosal absorption.

Professor Stow has been awarded multiple career fellowships including from American Heart Association, Wellcome Trust and NHMRC. She has published >200 papers, cited over 15,500 times and she is the recipient of awards and honours, most recently including the 2019 President's Medal from the Australia and New Zealand Society for Cell and Developmental Biology. She is also academic head of IMB Microscopy, a world-class fluorescence microscopy and image analysis facility. Her research is funded by a variety of agencies and industry partnerships, in addition to NHMRC and ARC, including through the ARC Centre of Excellence in Quantum Biotechnology, QUBIC. The Stow lab work with national and international collaborators and welcome students and postdoctoral trainees to participate in their research. We value having a diverse, inclusive and supportive culture for research and celebrate the many diverse and wonderful successes of Stow lab alumni.

MS has >30 years of clinical research experience in pathogenesis and management of hypertension (HT) and especially of endocrine varieties including primary aldosteronism (PA). Working within the Greenslopes Hospital Hypertension Unit (GHHU), he played a significant role in the demonstration that PA is much more common than previously thought, and in the description of a new familial form (FH-II). MS has made key contributions to understanding of steroid and BP regulation in another familial form (FH-I). The combined GHHU/Princess Alexandra Hospital HT Unit (PAHHU, which MS set up in 2000) has the largest series (>2000) worldwide of patients with PA who have been thoroughly documented and meticulously studied, helping MS to become internationally recognized as an authority on pathogenesis (including genetics), diagnostic workup and management of PA, including its familial forms. In 2006, he was invited to be a member of an international Task Force sponsored by the US Endocrine Society to develop clinical guidelines for the diagnosis and management of PA.

As at October 2018, MS had published or in press 205 full papers in peer-reviewed journals, 15 chapters for textbooks of medicine (including DeGroot's Endocrinology) and four on-line chapters (including one for Harrison's Online). According to ISI Web of Knowledge, MS’s journal publications have been cited >7000 times. Fifteen have been cited >100 times, one of these >900 (“h” index 44). He has been invited to speak at major meetings 120 times (84 international, 36 national) since 1998 including a debate with Norman Kaplan on the prevalence of PA (ISH, Prague 2002). He was invited by the University of WA to give the Robert Vandongen Memorial Lecture for 2002 and by the Cardiac Society of Australia and New Zealand to deliver the Gaston-Bauer Lecture in 2012. MS has collaborated with researchers in 14 international Units and all Australian states. In 2002, he was named as a Chief Investigator within a newly established Clinical Centre of Research Excellence (CCRE) in Cardiovascular Disease and Metabolic Disorders at Princess Alexandra Hospital, funding for which was renewed by the NHMRC in 2006 for 2007-11. In 2018 he became one of six international investigators to head a Transatlantic Network of Excellence investigating Potassium and Hypertension funded by the Leducq Foundation. Has served on Editorial Boards for J Hypertens, Clin Exper Physiol Pharmacol, Nephrology (Subject Editor), J Clin Endocrinol Metab and J Hum Hypertens (Co-Editor) and assessed manuscripts for >20 major international journals. Has served as written grant application assessor for six major international and five major national funding bodies, on NHF Grant Interviewing Committees in 1997, 1998, 1999, 2001 and 2002, and on NHMRC GRPs in 2003, 2005, 2006, 2007, 2008, 2010 and 2011. MS is a member of the International Society of Hypertension (ISH), American Society of Hypertension and US Endocrine Society. He was elected into the Executive Committee of the High BP Research Council of Australia in 1998, as Secretary in 2001 and as President in 2017. He also served as President of the Asia-Pacific Society of Hypertension in 2019. He was a Member of the NHF BP and Vascular Disease Advisory Committee from 1998 until 2012.

Other Awards and Honours:

NHMRC Postgraduate Medical Research Scholarship, 1992-94 John W.H. Tyrer Prize for Research in Internal Medicine, 1992 NHF Clinical Research Fellowship, 1995-97 NHF Postdoctoral Fellowship, 1998-99 Honorary Professor to the Xinjiang Institute of Hypertension, 2005 Member, Primary Aldosteronism Guidelines Task Force, US Endocrine Society, 2006 Visiting Professor, Tung Wah Eastern Hospital, Hong Kong, 2008 Honorary Professor of the Hypertension Department at Henan Provincial People’s Hospital, the Hypertension Control and Research Center of Henan Province, and the Hypertension Diagnosis and Treatment Center of Henan Province, 2009 Gaston Bauer Lecturer, Cardiac Society of Australia and New Zealand, 2012

Jenny was appointed Professor of Occupational Therapy in 1997. At the end of 2015, Jenny took early retirement from UQ. In January 2016, she was awarded the title of Emeritus Professor of The University of Queensland. Jenny is now using her time to facilitate and enable a new generation of clinical occupational therapists to appraise and utilise research evidence in their practice, and to conduct clinical research and generate new evidence to inform practice. In addition, she continues to guide a growing group of research higher degree students, while focusing more time upon her own research in the area of chronic pain.

Her research has primarily focused upon the impact which chronic pain has upon a person's life; the attendant measurement of that pain, and the efficacy of different treatment approaches. Jenny was recognised as a Distinguished Member of the Australian Pain Society in 2014, for her contribution to pain management education and research in Australia.

Professor David Sturgess is the Deputy Director of Anaesthesia (Professional Development) at the Princess Alexandra Hospital, Brisbane, Australia. He is also a Councillor (Non-executive Director) of the Australia and New Zealand College of Anaesthetists (ANZCA), as well as Medical lead & Co-chair of the Queensland Health Statewide Anaesthesia and Perioperative Network (SWAPNet).

Professor Sturgess' doctoral thesis focused upon the non-invasive evaluation of heart function during life threatening infection. This culminated in award of a Doctorate of Philosophy (PhD), in the Discipline of Anaesthesiology and Critical Care, from The University of Queensland. Professor Sturgess maintains a keen interest in haemodynamic monitoring and echocardiography.

The scope of his current research interests has broadened and is best collated under the theme of Perioperative Medicine. Professor Sturgess' research brings together elements of the inflammatory response, critical care equipment and inter-professional collaboration.

Postgraduate research student supervision and published collaborations include exploration of the interactions between opioids, regional anaesthesia and cancer recurrance; perioperative nutrition and hyperglycaemia; analysis and interpretation of large observational perioperative datasets; risk stratification of acute coronary syndromes using echocardiography; neuraxial anatomy and haemodynamics relevent to peripartum anaesthesia; implementation science and perioperative temperature monitoring and management.

Dr Michalis Stylianou is a senior lecturer with the School of Human Movement and Nutrition Sciences at The University of Queensland. His research interests focus around creating active and healthy schools using comprehensive and coordinated approaches that involve school staff, parents, and the community. Michalis is also a member of the Active Healthy Kids Australia research working group, a collaboration among Australian children’s physical activity and health researchers who advocate for actions to increase the physical activity levels among Australian children using the Physical Activity Report Card for Children and Young People as the core monitoring metric.

I am a biologist interested in the general question of how changes in developmental processes can lead to evolutionary variation and origin of complex traits (such as neural circuits). I study development and evolution of the brain of mammals. My doctoral thesis studied brain regions involved in olfactory and pheromonal communication in mammals. I discovered several events of parallel co-variation of sensory pathways in distantly related species sharing similar ecological niches, as cases of ontogenetic and phylogenetic plasticity. Currently, I study development and evolution of neocortical circuits by following two main lines of research: one aims to determine how early neuronal activity emerges during development and help shape brain connections, and the other one aims to understand what developmental processes led to evolutionary innovations in the mammalian brain. My research combines molecular development (electroporation, CRISPR), transcriptomics, sensory manipulations, neuroanatomy mapping (MRI, stereotaxic tracer injections, confocal and image analysis), optogenetics, and in vivo calcium imaging (multiphoton and widefield) in rodent pups and marsupial joeys.